The short version
GHK-Cu is the standout compound in this library for anyone interested in skin health. It has been studied for over 50 years, has genuinely controlled human trial data behind it, and sits quietly inside some of the best-regarded skincare products on the market. It is a small three-amino-acid peptide naturally bound to copper, and it signals the skin to produce more collagen, elastin and the structural components that make skin look fuller, firmer and more even. Among all the compounds on these pages, it has the strongest track record of actually doing what it says for skin.
How it works — in plain English
GHK-Cu is a signalling molecule. When applied to skin, it tells your cells that repair is needed — triggering production of collagen (the structural protein that keeps skin firm), elastin (which gives skin its bounce) and the water-holding compounds that give skin its plumpness. Copper is an essential cofactor for several of the enzymes that cross-link collagen and elastin into strong, resilient fibres. Skin's natural GHK-Cu levels fall with age, which is one reason skin becomes thinner and less elastic over time.
What the research actually shows
The human evidence is concentrated in topical applications and is more solid than most compounds in this library.
In controlled trials, GHK-Cu eye creams have outperformed both placebo and vitamin K cream for reducing fine lines and improving skin density. It has also been compared head-to-head with vitamin C and retinoic acid, with GHK-Cu producing collagen increases in the majority of volunteers. Animal and cell wound-healing models consistently show it boosting wound closure, blood vessel formation and collagen synthesis.
Topical vs injectable
GHK-Cu's strong reputation rests on its topical use. Injectable GHK-Cu is promoted in some peptide research circles, but that application has far less human evidence and sits in research-only territory. The well-supported use is applying it to skin in a quality cosmetic formulation.